C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/08 (2006.01) C12N 5/00 (2006.01) C12N 5/06 (2006.01) C12Q 1/02 (2006.01)
Patent
CA 2351156
The present inventors identified aggregation of embryoid bodies (EBs) as the cause of the difficulty in generating large numbers of the embryonic stem cells (ES) cell-derived tissues. To counter this, the invention provides a novel bioprocess where aggregation of EBs is physically prevented, such as by an encapsulating matrix, Liquid Suspension Culture- encapsulated (LSCe). As a result, EBs can be cultured in high cell density, well-mixed systems. Well- mixed conditions facilitate measurement and control of the bulk media conditions and allow for the use of scalable bioreactor systems for clinical production of tissue. Therefore, LSCe enables generation of ES cell-derived tissue on a clinical scale. The invention is also applicable to other types of pluripotent cells
Dang Stephen
Zandstra Peter W.
Bereskin & Parr
Dang Stephen
Zandstra Peter W.
LandOfFree
A bioprocess for the generation of pluripotent cell derived... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A bioprocess for the generation of pluripotent cell derived..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A bioprocess for the generation of pluripotent cell derived... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1843733